Horst Oexle, MD

Internal Medicine, Academic Teaching Hospital Hall in Triol, Hall in Tirol; present address: Reha Zentrum Münster, Austria

N/A

Poster(s):

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial